Hemochron (ACT)

Broadest test menu
ACT+ accurately measures heparin effects (1.0-6.0 u/mL blood); ACT-LR, sensitive to low heparin doses (0.0-2.5 u/mL blood), is the only low-range POC assay indicated for use during ECLS, Hemodialysis, PTCA. PT/Citrate PT and APTT/Citrate APTT reports INR, plasma-equivalent seconds, with an effective INR range of 0.8-10.0.

Complete Assay Menu:
ACT+, ACT-Low Range, PT, Citrate PT, APTT, Citrate APTT

Fast and simple
Fast, accurate and reproducible results for dose adjustments and clinical decisions. Faster true fibrin clot than any other system. Simple cuvette-based technology measures fibrin formation.

Connectivity and compliance
To maximize efficiency and ensure regulatory compliance, automatic internal electronic QC with lockout for cuvette and QC expiration, as well as operator tracking and lockout. Direct connection to Ethernet and major data management systems. POCT-1A compliant.